ZA912138B - Bcrf1 antagonists for treating epstein-barr virus infections - Google Patents

Bcrf1 antagonists for treating epstein-barr virus infections

Info

Publication number
ZA912138B
ZA912138B ZA912138A ZA912138A ZA912138B ZA 912138 B ZA912138 B ZA 912138B ZA 912138 A ZA912138 A ZA 912138A ZA 912138 A ZA912138 A ZA 912138A ZA 912138 B ZA912138 B ZA 912138B
Authority
ZA
South Africa
Prior art keywords
bcrf1
antagonists
barr virus
virus infections
treating
Prior art date
Application number
ZA912138A
Other languages
English (en)
Inventor
Kevin W Moore
W Moore Kevin
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA912138B publication Critical patent/ZA912138B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA912138A 1990-03-26 1991-03-21 Bcrf1 antagonists for treating epstein-barr virus infections ZA912138B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49898590A 1990-03-26 1990-03-26

Publications (1)

Publication Number Publication Date
ZA912138B true ZA912138B (en) 1991-12-24

Family

ID=23983319

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912138A ZA912138B (en) 1990-03-26 1991-03-21 Bcrf1 antagonists for treating epstein-barr virus infections

Country Status (23)

Country Link
US (1) US5756342A (no)
EP (1) EP0522010B1 (no)
JP (1) JP2509774B2 (no)
KR (1) KR960004856B1 (no)
CN (1) CN1056245A (no)
AT (1) ATE126704T1 (no)
AU (1) AU650013B2 (no)
CA (1) CA2079230C (no)
DE (1) DE69112392T2 (no)
DK (1) DK0522010T3 (no)
ES (1) ES2076526T3 (no)
FI (1) FI924278A (no)
GR (1) GR3017920T3 (no)
HU (1) HUT63339A (no)
IE (1) IE70910B1 (no)
IL (1) IL97629A0 (no)
MX (1) MX9203522A (no)
MY (1) MY106163A (no)
NO (1) NO923749D0 (no)
OA (1) OA09674A (no)
PT (1) PT97108B (no)
WO (1) WO1991014451A1 (no)
ZA (1) ZA912138B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998010792A1 (en) * 1996-09-11 1998-03-19 Prendergast Patrick T Immune direction therapy
CN111574621B (zh) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 一种中和eb病毒的单克隆抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614810A (en) * 1984-09-24 1986-09-30 Pennwalt Corporation 4,5-dihydro-4-oxo-2-[(2-trans-phenylcyclopropyl)amino]-3-furancarboxylic acids and derivatives thereof
US5231012A (en) * 1989-06-28 1993-07-27 Schering Corporation Nucleic acids encoding cytokine synthesis inhibitory factor (interleukin-10)

Also Published As

Publication number Publication date
JPH05501116A (ja) 1993-03-04
EP0522010A1 (en) 1993-01-13
FI924278A0 (fi) 1992-09-24
GR3017920T3 (en) 1996-01-31
ATE126704T1 (de) 1995-09-15
MX9203522A (es) 1992-07-01
NO923749L (no) 1992-09-25
CA2079230C (en) 2001-02-13
EP0522010B1 (en) 1995-08-23
OA09674A (en) 1993-05-15
US5756342A (en) 1998-05-26
AU650013B2 (en) 1994-06-09
ES2076526T3 (es) 1995-11-01
IE70910B1 (en) 1997-01-15
CA2079230A1 (en) 1991-09-27
CN1056245A (zh) 1991-11-20
NO923749D0 (no) 1992-09-25
KR960004856B1 (ko) 1996-04-16
PT97108B (pt) 1998-10-30
MY106163A (en) 1995-03-31
IL97629A0 (en) 1992-06-21
WO1991014451A1 (en) 1991-10-03
PT97108A (pt) 1991-11-29
DE69112392D1 (de) 1995-09-28
DK0522010T3 (da) 1996-01-15
IE910942A1 (en) 1991-10-09
DE69112392T2 (de) 1996-02-01
FI924278A (fi) 1992-09-24
AU7588291A (en) 1991-10-21
JP2509774B2 (ja) 1996-06-26
HUT63339A (en) 1993-08-30

Similar Documents

Publication Publication Date Title
MY107079A (en) Method of reducing immunoglobulin e responses
GB9009106D0 (en) Processes and intermediates for synthetic antibody derivatives
MY107386A (en) Method of preventing or reducing eosinophilia
WO1991007986A8 (en) Method of treating septic shock
IL97629A0 (en) Bcrf1 antagonists for treating epstein-barr virus infections
ES2013665A6 (es) Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.